Immune Profiling To Predict Outcome of Clostridioides difficile Infection.

mBio · 2020 · PMC7251209 · PMID 32457246

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

a strong trendP = 0.07so close (0.05 < p ≤ 0.1)

Interestingly, when data from all the patients irrespective of their prior CDI history were included in the analysis, CCL-5 was the sole biomarker that showed a strong trend ( P = 0.07) toward association with 90-day recurrence.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.